Resultats de la cerca - Devos, David
- Mostrar 1 - 20 resultats de 46
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates per Gouel, Flore, Rolland, Anne-Sophie, Devedjian, Jean-Christophe, Burnouf, Thierry, Devos, David
Publicat 2019Text -
6
Joint latent class model: Simulation study of model properties and application to amyotrophic lateral sclerosis disease per Kyheng, Maéva, Babykina, Génia, Ternynck, Camille, Devos, David, Labreuche, Julien, Duhamel, Alain
Publicat 2021Text -
7
-
8
Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation per Devos, David, Tchofo, P. Jissendi, Vuillaume, Isabelle, Destée, Alain, Batey, Stephanie, Burn, John, Chinnery, Patrick F.
Publicat 2009Text -
9
Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease per Duce, James A., Wong, Bruce X., Durham, Hannah, Devedjian, Jean-Christophe, Smith, David P., Devos, David
Publicat 2017Text -
10
-
11
-
12
Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models? per Hopfner, Franziska, Hobert, Markus A., Maetzler, Corina, Hansen, Clint, Pham, Minh Hoang, Moreau, Caroline, Berg, Daniela, Devos, David, Maetzler, Walter
Publicat 2019Text -
13
Mapping Spatiotemporal Microproteomics Landscape in Experimental Model of Traumatic Brain Injury Unveils a link to Parkinson's Disease per Mallah, Khalil, Quanico, Jusal, Raffo-Romero, Antonella, Cardon, Tristan, Aboulouard, Soulaimane, Devos, David, Kobeissy, Firas, Zibara, Kazem, Salzet, Michel, Fournier, Isabelle
Publicat 2019Text -
14
Texture-based markers from structural imaging correlate with motor handicap in Parkinson’s disease per Betrouni, Nacim, Moreau, Caroline, Rolland, Anne-Sophie, Carrière, Nicolas, Chupin, Marie, Kuchcinski, Gregory, Lopes, Renaud, Viard, Romain, Defebvre, Luc, Devos, David
Publicat 2021Text -
15
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease per Odin, Per, Chaudhuri, K. Ray, Volkmann, Jens, Antonini, Angelo, Storch, Alexander, Dietrichs, Espen, Pirtošek, Zvezdan, Henriksen, Tove, Horne, Malcolm, Devos, David, Bergquist, Filip
Publicat 2018Text -
16
The role of the surface ligand on the performance of electrochemical SARS-CoV-2 antigen biosensors per Szunerits, Sabine, Pagneux, Quentin, Swaidan, Abir, Mishyn, Vladyslav, Roussel, Alain, Cambillau, Christian, Devos, David, Engelmann, Ilka, Alidjinou, Enagnon Kazali, Happy, Henri, Boukherroub, Rabah
Publicat 2021Text -
17
The Antibody Dependant Neurite Outgrowth Modulation Response Involvement in Spinal Cord Injury per Capuz, Alice, Karnoub, Mélodie-Anne, Osien, Sylvain, Rose, Mélanie, Mériaux, Céline, Fournier, Isabelle, Devos, David, Vanden Abeele, Fabien, Rodet, Franck, Cizkova, Dasa, Salzet, Michel
Publicat 2022Text -
18
Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder per Ganapathy S., Ranjani, Levová, Kateřina, Kotačková, Lenka, Trnka, Jiří, Zogala, David, Rusz, Jan, Zima, Tomáš, Devos, David, Šonka, Karel, Růžička, Evžen, Kalousová, Marta, Dušek, Petr
Publicat 2022Text -
19
-
20
Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease per Grolez, Guillaume, Moreau, Caroline, Sablonnière, Bernard, Garçon, Guillaume, Devedjian, Jean-Christophe, Meguig, Sayah, Gelé, Patrick, Delmaire, Christine, Bordet, Regis, Defebvre, Luc, Cabantchik, Ioav Z, Devos, David
Publicat 2015Text